155 related articles for article (PubMed ID: 9085130)
21. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
Klug TL; Green PJ; Zurawski VR; Davis HM
Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
[TBL] [Abstract][Full Text] [Related]
22. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.
Ma J; Zhou L; Wang D
Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811
[TBL] [Abstract][Full Text] [Related]
23. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies and idiotypic network activation for ovarian carcinoma.
Wagner U; Reinsberg J; Schmidt S; Mallmann P; Schmolling J; Schultes B; Richter H; Biersack HJ; Krebs D
Cell Biophys; 1994; 24-25():237-42. PubMed ID: 7736528
[TBL] [Abstract][Full Text] [Related]
25. Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.
Baum RP; Noujaim AA; Nanci A; Moebus V; Hertel A; Niesen A; Donnerstag B; Sykes T; Boniface G; Hör G
Hybridoma; 1993 Oct; 12(5):583-9. PubMed ID: 8300134
[No Abstract] [Full Text] [Related]
26. [Cytotoxic action of monoclonal antibodies OC125 and SH-9 on ovarian cancer cell lines].
Murakami F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):125-32. PubMed ID: 8718548
[TBL] [Abstract][Full Text] [Related]
27. Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13.
Drugs R D; 2006; 7(6):379-83. PubMed ID: 17073521
[TBL] [Abstract][Full Text] [Related]
28. Idiotypic cascades after MAb OC125 application.
Reinsberg J
Hybridoma; 1993 Oct; 12(5):577-82. PubMed ID: 8300133
[No Abstract] [Full Text] [Related]
29. Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12.
Schmitt H; Khazaeli MB; Rodenburg CM; Kaul S; Bastert G
Hybridoma; 1994 Oct; 13(5):389-96. PubMed ID: 7532153
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
31. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
32. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
Li AD; Li Z; Wang YH; Zhang YM; Ma J
Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
[TBL] [Abstract][Full Text] [Related]
33. [Generation of genetic engineering anti-idiotypic antibody against OC125 monoclonal antibody of ovarian carcinoma].
Zhang X; Cui H; Qian H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):646-8. PubMed ID: 9387521
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.
Ronay G; Jäger W; Weiss K; Feistel H; Wolf F; Tulusan AH; Lang N
Br J Cancer Suppl; 1990 Jul; 10():67-9. PubMed ID: 2200498
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
[TBL] [Abstract][Full Text] [Related]
36. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
37. Idiotypic determinants of monoclonal antibodies that bind to 3-fucosyllactosamine.
Umeda M; Diego I; Ball ED; Marcus DM
J Immunol; 1986 Apr; 136(7):2562-7. PubMed ID: 2419441
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of anti-idiotypic antibodies and of their F(ab')2 fragments.
Tassi V; Ruggiero G; Rosaia L; Lorenzoni P; Ceccarini C; Tecce MF
Immunol Lett; 1991 Jan; 27(1):39-43. PubMed ID: 1708352
[TBL] [Abstract][Full Text] [Related]
39. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies.
Hirashima K; Zenita K; Takada A; Kitahara A; Ishihara G; Harada R; Ohmori K; Hirohashi S; Kyoizumi S; Akiyama M
J Immunol; 1990 Jul; 145(1):224-32. PubMed ID: 1972718
[TBL] [Abstract][Full Text] [Related]
40. Induction of anti-viral immune response by immunization with monoclonal anti-idiotype antibodies directed to private idiotopes.
Osterhaus AD; Rimmelzwaan GF; Weijer K; Uytdehaag AG
Viral Immunol; 1989; 2(4):255-62. PubMed ID: 2482029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]